Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60 years of age or older (2018)
- Authors:
- USP affiliated authors: SARTORI, ANA MARLI CHRISTOVAM - FM ; NOVAES, HILLEGONDA MARIA DUTILH - FM ; SOÁREZ, PATRÍCIA COELHO DE - FM
- Unidade: FM
- DOI: 10.1016/j.vaccine.2018.03.070
- Subjects: REVISÃO SISTEMÁTICA; CUSTOS DOS CUIDADOS DE SAÚDE; PREVENÇÃO DE DOENÇAS; CAMPANHAS DE VACINAÇÃO
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo NÃO é de acesso aberto
-
ABNT
NISHIKAWA, Alvaro Mitsunori et al. Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60 years of age or older. Vaccine, v. 36, n. 19, p. 2510-2522, 2018Tradução . . Disponível em: https://doi.org/10.1016/j.vaccine.2018.03.070. Acesso em: 27 fev. 2026. -
APA
Nishikawa, A. M., Sartori, A. M. C., Novaes, H. M. D., & Soarez, P. C. de. (2018). Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60 years of age or older. Vaccine, 36( 19), 2510-2522. doi:10.1016/j.vaccine.2018.03.070 -
NLM
Nishikawa AM, Sartori AMC, Novaes HMD, Soarez PC de. Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60 years of age or older [Internet]. Vaccine. 2018 ; 36( 19): 2510-2522.[citado 2026 fev. 27 ] Available from: https://doi.org/10.1016/j.vaccine.2018.03.070 -
Vancouver
Nishikawa AM, Sartori AMC, Novaes HMD, Soarez PC de. Systematic review of economic evaluations of the 23-valent pneumococcal polysaccharide vaccine (PPV23) in individuals 60 years of age or older [Internet]. Vaccine. 2018 ; 36( 19): 2510-2522.[citado 2026 fev. 27 ] Available from: https://doi.org/10.1016/j.vaccine.2018.03.070 - Cost-effectiveness analysis of universal maternal immunization with tetanus-diphtheria-acellular pertussis (Tdap) vaccine in Brazil
- Systematic review of economic evaluation studies for dengue vaccine: how valid are the results?
- Budget impact analysis of vaccines: what are the methodological issues?
- Revisão sistemática das diretrizes de análise de impacto
- Challenges of interpreting epidemiologic surveillance pertussis data with changing diagnostic and immunization practices: the case of the state of Sao Paulo, Brazil
- Systematic review of cost-effectiveness of vaccinating elderly whit the 23-valent pneumococcal polysaccharide vaccine (PPV23)
- Annual national direct and indirect cost estimates of the prevention and treatment of cervical cancer in Brazil
- Economic evaluation of adolescents and adults' pertussis vaccination: a systematic review of current strategies
- Methods and challenges for the health impact assessment of vaccination programs in Latin America
- Cost-Effectiveness Analysis of Universal Vaccination of Adults Aged 60 Years with 23-Valent Pneumococcal Polysaccharide Vaccine versus Current Practice in Brazil
Informações sobre o DOI: 10.1016/j.vaccine.2018.03.070 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
